DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

Timothy J. Ley, Elaine R. Mardis (), Li Ding, Bob Fulton, Michael D. McLellan, Ken Chen, David Dooling, Brian H. Dunford-Shore, Sean McGrath, Matthew Hickenbotham, Lisa Cook, Rachel Abbott, David E. Larson, Dan C. Koboldt, Craig Pohl, Scott Smith, Amy Hawkins, Scott Abbott, Devin Locke, LaDeana W. Hillier, Tracie Miner, Lucinda Fulton, Vincent Magrini, Todd Wylie, Jarret Glasscock, Joshua Conyers, Nathan Sander, Xiaoqi Shi, John R. Osborne, Patrick Minx, David Gordon, Asif Chinwalla, Yu Zhao, Rhonda E. Ries, Jacqueline E. Payton, Peter Westervelt, Michael H. Tomasson, Mark Watson, Jack Baty, Jennifer Ivanovich, Sharon Heath, William D. Shannon, Rakesh Nagarajan, Matthew J. Walter, Daniel C. Link, Timothy A. Graubert, John F. DiPersio and Richard K. Wilson
Additional contact information
Timothy J. Ley: Department of Medicine,
Elaine R. Mardis: Department of Genetics,
Li Ding: Department of Genetics,
Bob Fulton: The Genome Center at Washington University,
Michael D. McLellan: The Genome Center at Washington University,
Ken Chen: The Genome Center at Washington University,
David Dooling: The Genome Center at Washington University,
Brian H. Dunford-Shore: The Genome Center at Washington University,
Sean McGrath: The Genome Center at Washington University,
Matthew Hickenbotham: The Genome Center at Washington University,
Lisa Cook: The Genome Center at Washington University,
Rachel Abbott: The Genome Center at Washington University,
David E. Larson: The Genome Center at Washington University,
Dan C. Koboldt: The Genome Center at Washington University,
Craig Pohl: The Genome Center at Washington University,
Scott Smith: The Genome Center at Washington University,
Amy Hawkins: The Genome Center at Washington University,
Scott Abbott: The Genome Center at Washington University,
Devin Locke: The Genome Center at Washington University,
LaDeana W. Hillier: The Genome Center at Washington University,
Tracie Miner: The Genome Center at Washington University,
Lucinda Fulton: The Genome Center at Washington University,
Vincent Magrini: Department of Genetics,
Todd Wylie: The Genome Center at Washington University,
Jarret Glasscock: The Genome Center at Washington University,
Joshua Conyers: The Genome Center at Washington University,
Nathan Sander: The Genome Center at Washington University,
Xiaoqi Shi: The Genome Center at Washington University,
John R. Osborne: The Genome Center at Washington University,
Patrick Minx: The Genome Center at Washington University,
David Gordon: University of Washington, Seattle, Washington 98195, USA
Asif Chinwalla: The Genome Center at Washington University,
Yu Zhao: Department of Medicine,
Rhonda E. Ries: Department of Medicine,
Jacqueline E. Payton: Department of Pathology and Immunology,
Peter Westervelt: Department of Medicine,
Michael H. Tomasson: Department of Medicine,
Mark Watson: The Genome Center at Washington University,
Jack Baty: and
Jennifer Ivanovich: Siteman Cancer Center,
Sharon Heath: Department of Medicine,
William D. Shannon: Department of Medicine,
Rakesh Nagarajan: Siteman Cancer Center,
Matthew J. Walter: Department of Medicine,
Daniel C. Link: Department of Medicine,
Timothy A. Graubert: Department of Medicine,
John F. DiPersio: Department of Medicine,
Richard K. Wilson: Department of Genetics,

Nature, 2008, vol. 456, issue 7218, 66-72

Abstract: Abstract Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about 13,000 adults in the United States each year. The treatment of this disease has changed little in the past two decades, because most of the genetic events that initiate the disease remain undiscovered. Whole-genome sequencing is now possible at a reasonable cost and timeframe to use this approach for the unbiased discovery of tumour-specific somatic mutations that alter the protein-coding genes. Here we present the results obtained from sequencing a typical acute myeloid leukaemia genome, and its matched normal counterpart obtained from the same patient’s skin. We discovered ten genes with acquired mutations; two were previously described mutations that are thought to contribute to tumour progression, and eight were new mutations present in virtually all tumour cells at presentation and relapse, the function of which is not yet known. Our study establishes whole-genome sequencing as an unbiased method for discovering cancer-initiating mutations in previously unidentified genes that may respond to targeted therapies.

Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://www.nature.com/articles/nature07485 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:456:y:2008:i:7218:d:10.1038_nature07485

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature07485

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().